Homocysteine metabolism

Annual Review of Nutrition

Volumn 19, Issue , 1999, Pages 217-246

  Selhub, J ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Folate; Vitamin B12; Vitamin B6

Indexed keywords

HOMOCYSTEINE;

AMINO ACID METABOLISM; BLOOD CLOTTING; BLOOD VESSEL WALL; HUMAN; HYPERHOMOCYSTEINEMIA; METHYLATION; PRIORITY JOURNAL; PYRIDOXINE DEFICIENCY; REVIEW;

ANIMALS; HOMEOSTASIS; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; NUTRITION PHYSIOLOGY; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS;

ANIMALIA;

EID: 0032771346     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.19.1.217     Document Type: Review

References (150)

1. 1. Abbate R, Sardi I, Pepe G, Marcucci R, Brunelli T, et al. 1998. The high prevalence of thermolabile 5-10 methylene-tetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD). Thromb. Haemost. 79:727-30
2. 2. Adams M, Smith PD, Martin D, Thompson JR, Samani NJ. 1996. Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction. Q. J. Med. 89:437-44
3. 3. Andrade FL, Annichino-Bizzacchi JM, Saad ST, Costa FF, Arruda VR. 1998. Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil. Am. J. Hematol. 59:46-50
4. 4. Applegarth DA, Hardwick DF, Ingram F, Auckland NL, Bozoian G. 1971. Excretion of S-adenosylmethionine and S-adenosylhomocysteine in homocystinuria. N. Engl. J. Med. 285:1265-66
5. 5. Arruda VR, von Zuben PM Chiaparini LC, Annichino-Bizzacchi JM, Costa FF. 1997. The mutation Ala677 → Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb. Haemost. 77:818-21
6. 6. Balaghi M, Horne DW, Wagner C. 1993. Hepatic one-carbon metabolism in early folate deficiency in rats. Biochem. J. 291:145-49
7. 7. Bell TR, Edman JS, Selhub J, Morrow FD, Marby DW, et al. 1992. Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatr. Scand. 86:386-90
8. 8. Boers GHJ, Fowler B, Smals AGH, Trijbels FJ, Leermakers AI, et al. 1985. Improved identification of heterozygotes for homocystinuria due to cysthathionine synthase activity by the combination of methionine loading and enzyme determination in cultured fibroblasts. Hum. Genet. 69:164-69
9. 9. Bostom AG, Gohh RY, Beaulieu AJ, Nadeau MR, Hume AL, et al. 1997. Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial. Ann. Intern. Med. 127:1089-92
10. 10. Bostom AG, Jacques PF, Nadeau MR, Williams RR, Ellison RC, Selhub J. 1995. Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine - initial results from the NHLBI Family Heart Study. Atherosclerosis 116:147-51
11. 11. Bostom A, Silbershatz H, Jacques P, Selhub J, D'Agostino R, et al. 1999. Non-fasting plasma total homocysteine levels and all-cause cardiovascular disease mortality in elderly Framingham men and women. Arch. Intern. Med. In press
12. 12. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. 1995. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049-57
13. 13. Brattstrom L, Israelsson B, Lindgarde F, Hultberg B. 1988. Higher total plasma homocysteine in vitamin B deficiency than in heterozygosity for homocystinuria due to cystathionine ß-synthase deficiency. Metabolism 37:175-78
14. 14. Brattstrom L, Israelsson B, Norrving B, Bergqvist D, Throne J, et al. 1990. Impaired homocysteine metabolism in early onset cerebral and peripheral occlusive arterial disease - effects of pyridoxine and folic acid treatment. Atherosclerosis 81:51-60
15. 15. Brattstrom L, Israelsson B, Tengborn L, Hultberg B. 1989. Homocysteine, factor VII and amithrombin III in subjects with different gene dosage for cystathionine ß-synthase. J. Inherit. Metab. Dis. 12:475-82
16. 16. Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B. 1994. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J. Intern. Med. 236:633-41
17. 17. Brattstrom LE, Israelsson B, Jeppsson J-O, Hultberg BL. 1988. Folic acid - an innocuous means to reduce plasma homocysteine. Scand. J. Clin. Lab. Invest. 48:215-21
18. 18. Cabrero C, Martin-Duce A, Ortiz P, Alemany S, Mato JM. 1998. Specific loss of the high molecular weight form of S-adenosyl-L-methionine synthetase in human liver cirrhosis. Hepatology 8: 1530-34
19. 19. Cabrero C, Puerta J, Alemany S. 1987. Purification and comparison of two forms of S-adenosyl-L-methionine synthetase from rat liver. Eur. J. Biochem. 170:299-304
20. 20. Chapman J, Wang N, Treves TA, Korczyn AD, Bornstein NM. 1998. ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. Stroke 29:1401-4
21. 21. Christensen B, Frosst P, Lussier-Cacan S, Selhub J, Goyette P, et al. 1997. Correlation of a common mutation in the methylenetetrahydrofolate reductase (MTHFR) gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler. Thromb. Vasc. Pathol. 17:569-73
22. 22. Christensen B, Refsum H, Vintermyr O, Ueland PM. 1991. Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: methionine loading of nontransformed, transformed, proliferating, and quiescent cells in culture. J. Cell Biol. 146:52-62
23. 23. Clarke R. 1990. The Irish experience. In Homocysteinaemia and Vascular Disease, ed. K Robinson, pp. 41-48. Luxembourg: Comm. Eur. Communities
24. 24. Cook RJ, Wagner C. 1984. Glycine N-methyltransferase is a folate binding protein of rat liver cytosol. Proc. Natl. Acad. Sci. USA 81:3631-34
25. 25. Coppola A, Albisinni R, Madonna P, Pagano A, Cerbone AM, Di Minno G. 1997. Platelet and monocyte variables in homocystinuria due to cystathionine-beta-synthase deficiency. Haematologica 82:189-90
26. 26. Dalery K, Lussier-Cacan S, Selhub J, Davignon J, Latour Y, Genest J. 1995. Homocysteine and coronary artery disease in French Canadian subjects: relationship with vitamin B12, B6, pyridoxal phosphate and folate. Am. J. Cardiol. 75:1107-11
27. 27. Dalton M, Gadson P, Wrenn R, Rosenquist TH. 1997. Homocysteine signal cascade. Production of phospholipids, activation of protein C kinase and induction of c-fos and c-myb in smooth muscle cells. FASEB J. 11:703-11
28. 28. D'Angelo A, Selhub J. 1997. Homocysteine and thrombotic disease. Blood 90:1-11
29. 29. de Franchis R, Mancini FP, D'Angelo A, Sebastio G, Fermo I, et al. 1996. Elevated total plasma homocysteine (tHcy) and 677CT mutation of the 5,10-methylene-tetrahydrofolate reductase gene in thrombotic vascular disease. Am. J. Hum. Genet. 59:262-64
30. 30. De Stefano V, Chiusolo P, Paciaroni K, Casorelli I, Rossi E, et al. 1998. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood 91:3562-65
31. 31. Dillon MJ, England JM, Gompertz D, Goodey PA, Grant DB, et al. 1974. Mental retardation, megaloblastic anaemia, methylmalonic aciduria and abnormal homocysteine metabolism due to an error in vitamin B12 metabolism. Clin. Sci. Mol. Med. 47:43-61
32. 32. Di Minno G, Davi G, Margaglione M, Cirillo F, Grandone E, et al. 1993. Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and Probucol-sensitive mechanism. J. Clin. Invest. 92: 1400-6
33. 33. Dudman NPB, Wilcken DEL, Wang J, Lynch JF, Macey D, Lundberg P. 1993. Disordered methionine/homocysteine metabolism in premature vascular disease: its occurrence, cofactor therapy, and enzymology. Arterioscler. Thromb. 13: 1253-60
34. 34. Dunn J, Title LM, Bata I, Johnstone DE, Kirkland SA, et al. 1998. Relation of a common mutation in methylenetetrahydrofolate reductase to plasma homocysteine and early onset coronary artery disease. Clin. Biochem. 31:95-100
35. 35. Durand P, Prost M, Blache D. 1996. Prothrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids. Atherosclerosis 121:231-43
36. 36. Eloranta TO, Martikainen V, Smith TK. 1990. Adaptation of adenosylmethionine metabolism and methionine recycling to variations in dietary methionine in the rat. Proc. Soc. Exp. Biol. Med. 194:364-71
37. 37. Fenton WA, Rosenberg LE. 1989. Inherited disorders of cobalamin transport and metabolism. In The Metabolic Basis of Inherited Disease, ed. CR Scriver, AL Beaudet, WS Sly, D Valle, p. 2065. New York: McGraw-Hill
38. 38. Fijnheer R, Roest M, Haas FJ, De Groot PG, Derksen RH. 1998. Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study. J. Rheumatol. 25:1737-42
39. 39. Finkelstein JD, Martin JJ. 1984. Methionine metabolism in mammals: distribution of homocysteine between competing pathways. J. Biol. Chem. 259:9508-13
40. 40. Folsom AR, Nieto FJ, McGovern PG, Tsai MY, Malinow MR, et al. 1998. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 98:204-10
41. 41. Franken DG, Boers GHJ, Blom HJ, Trijbels FJM. 1994. Effect of various regimens of vitamin B-6 and folic acid on mild hyperhomocysteinemia in vascular patients. J. Inherit. Metab. Dis. 17:159-62
42. 42. Franken DG, Boers GHJ, Blom HJ, Trijbels FJM, Kloppenborg PW. 1994. Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscl. Thromb. 14:465-70
43. 43. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10:111-13
44. 44. Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM. 1993. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler. Thromb. 13:1327-33
45. 45. Gallagher PM, Meleady R, Shields DC, Tan KS, McMaster D, et al. 1996. Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation. Circulation 94:2154-58
46. 46. Giannini MJ, Coleman M, Innerfield I. 1975. Antithrombin activity on homocystinuria. Lancet 1:1094
47. 47. Girelli D, Friso S, Trabetti E, Olivieri O, Russo C, et al. 1998. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. Blood 91:4158-63
48. 48. Goyette P, Frosst P, Rosenblatt DS, Rozen R. 1995. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am. J. Hum. Genet. 56:1052-59
49. 49. Goyette P, Sumner JS, Milos R, Duncan MV, Rosenblatt DS, et al. 1994. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat. Genet. 7: 195-204
50. 50. Halvorsen B, Brude I, Drevon CA, Nysom J, Ose L, et al. 1996. Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein. J. Lipid Res. 37:1591-600
51. 51. Harker LA, Slichter SJ, Scott CR, Ross R. 1974. Homocysteinemia. Vascular injury and arterial thrombosis. N. Engl. J. Med. 291:537-43
52. 52. Herbert V, Zalusky R. 1962. Interrelation of vitamin B12 and folic metabolism: folic acid clearance studies. J. Clin. Invest. 41:1263-76
53. 53. Hill-Zobel RL, Pyeritz RE, Scheffel U, Malpica O, Engin S, et al. 1982. Kinetics and distribution of 111 -Indium-labeled platelets in patients with homocystinuria. N. Engl. J. Med. 307:781-86
54. 54. Hollowell JG Jr, Hall WK, Coryell ME, McPherson J, Hahn DA. 1969. Homocystinuria and organic aciduria in a patient with vitamin B12 deficiency. Lancet 2:1428
55. 55. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, et al. 1996. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7-9
56. 56. Joosten E, Lesaffre E, Riezler R, Ghekiere V, Dereymaeker L, et al. 1998. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J. Gerontol.: Biol. Sci. Med. Sci. 52:M76-79
57. 57. Kang SS, Passen EL, Ruggie N, Wong PWK, Sora H. 1993. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation 88:1463-69
58. 58. Kang SS, Wong PWK, Norusis M. 1987. Homocysteinemia due to folate deficiency. Metabolism 36:458-62
59. 59. Kang SS, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N. 1991. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am. J. Hum. Genet. 48:536-45
60. 60. Kang SS, Wong PWK, Zhou JM, Sora J, Lessick M, et al. 1988. Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. Metabolism 37:611-13
61. 61. Kang SS, Zhou J, Wong PWK, Kowalisyn J, Strokosch G. 1988. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am. J. Hum. Genet. 43:414-21
62. 62. Kanwar JS, Manaligod JR, Wong PWK. 1976. Morphologic studies in a patient with homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Pediatr. Res. 10:598-609
63. 63. Keaney JF, Loscalzo J. 1997. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J. Biol. Chem. 272: 17012-17
64. 64. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. 1993. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q. J. Med. 86:703-8
65. 65. Kluijtmans LAJ, van den Heuvel LP, Boers GHJ, Frosst P, Stevens EMB, et al. 1996. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the 5,10-methylenetetrahydrofolate reductase gene is a genetic factor for cardiovascular disease. Am. J. Hum. Genet. 58:35-41
66. 66. Kluijtmans LA, Boers GH, Verbruggen B, Trijbels FJ, Novakova IR, Blom HJ. 1998. Homozygous cystathionine betasynthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis. Blood 91:2015-18
67. 67. Kokame K, Kato H, Miyata T. 1996. Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. J. Biol. Chem. 271:29659-65
68. 68. Koracevic D, Djordjevic V. 1977. Effect of trypsin, S-adenosylmethionine and ethionine on L-serine sulfhydrase activity. Experientia 33:1010-11
69. 69. Kostulas K, Crisby M, Huang WX, Lannfelt L, Hagenfeldt L, et al. 1998. A methylenetetrahydrofolate reductase gene polymorphism in ischaemic stroke and in carotid artery stenosis. Eur. J. Clin. Invest. 28:285-89
70. 70. Kozich V, Kraus E, de Franchis R, Fowler B, Boers GHJ, et al. 1995. Hyperhomocysteinemia in premature arterial disease: examination of cystathionine ß-synthase alleles at the molecular level. Hum. Mol. Genet. 4:623-29
71. 71. Kozich V, Kraus JP. 1992. Screening for mutations by expressing cDNA segments in E. Coli: homocystinuria due to cystathionine ß-synthase deficiency. Hum. Mutat. 1:113-23
72. 72. Kutzbach C, Stokstad ELR. 1967. CK inhibition of methylene-tetrahydrofolate reductase in rat liver by S-adenosyl-methionine. Biochim. Biophys. Acta 139: 217-20
73. 73. Kutzbach C, Stokstad ELR. 1971. Mammalian methylenetetrahydrofolate reductase: partial purification, properties, and inhibition by S-adenosylmethionine. Biochim. Biophys. Acta 250:459-77
74. 74. Lentz RS, Sobey CG, Pigeors DJ, Bhopatkar MY, Faraci FM, et al. 1996. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J. Clin. Invest. 98:24-29
75. 75. Levy HL, Cardinale GJ. 1970. Sulfur amino acid abnormalities in experimental vitamin B12 deficiency. Fed. Proc. 29:634
76. 76. Levy HL, Mudd SH, Schulman JD, Dreyfus PM, Abeles RH. 1970. A derangement in B12 metabolism associated with homocysteinemia, cystathioninemia, hypomethioninemia and methylmalonic aciduria. Am. J. Med. 48:390-97
77. 77. Lin JY, Kang SS, Zhou J, Wong PWK. 1989. Homocysteinemia in rats induced by folic acid deficiency. Life Sci. 44:319-25
78. 78. Lindenbaum J, Healton EB, Savage DG, Brust JC, Garrett TJ, et al. 1988. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N. Engl. J. Med. 318:1720-28
79. 79. Lindgren F, Israelsson B, Lindgren A, Hultberg B, Andersson A, Brattstrom L. 1995. Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid. J. Intern. Med. 237:381-88
80. 80. Loscalzo J. 1996. The oxidant stress of hyperhomocyst(e)inemia. J. Clin. Invest. 98:5-7
81. 81. Lubec B, Labudova O, Hoeger H, Muehl A, Fang-Kircher S, et al. 1996. Homocysteine increases cyclin-dependent kinase in aortic rat tissue. Circulation 94:2620-25
82. 82. Ma J, Stampfer MJ, Hennekens CH, Forst P, Selhub J, et al. 1996. Methylenetetrahydrofolate reductase polymorphism and risk of myocardial infarction in the U.S. physicians. Circulation 94:2410-16
83. 83. Malik NM, Syrris P, Schwartzman R, Kaski JC, Crossman DC, et al. 1998. Methylenetetrahydrofolate reductase polymorphism (C-677T) and coronary artery disease. Clin. Sci. 95:311-15
84. 84. Margaglione M, D'Andrea G, d'Addedda M, Giuliani N, Cappucci G, et al. 1998. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb. Haemost. 79:907-11
85. 85. Maruyama I, Fukuda R, Kaszmama M, Abe T, Yoshida Y, Igata A. 1977. A case of homocystinuria with low antithrombin activity. Acta Haematol. Jpn. 40:267-71
86. 86. Mayer EL, Jacobsen DE, Robinson K. 1996. Homocysteine and coronary atherosclerosis. J. Am. Coll. Cardiol. 27:517-27
87. 87. McCaddon A, Davies G, Hudson P, Tandy S, Cattell H. 1998. Total serum homocysteine in senile dementia of Alzheimer type. Int. J. Geriatr. Psychiatry 13:235-39
88. 88. McCully KS. 1969. Vascular pathology of homocysteinemia: implications for pathogenesis of arteriosclerosis. Am. J. Pathol. 56:111-28
89. 89. Merckx J, Kuntz F. 1981. Deficit en facteur VII et homocystinurie: association fortuite ou syndrome? Nouv. Presse Med. 10:3796
90. 90. Miller JW, Nadeau MR, Smith D, Selhub J. 1994. Vitamin B6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats. Am. J. Clin. Nutr. 59:1033-39
91. 91. Miller JW, Nadeau MR, Smith J, Smith D, Selhub J. 1994. Folate deficiency-induced homocysteinemia in rats: disruption of S-adenosylmethionine's coordinate regulation of homocysteine metabolism. Biochem. J. 298:415-19
92. 92. Miller JW, Ribaya-Mercado JD, Russell RM, Shepard DC, Morrow FD, et al. 1992. Total homocysteine in fasting plasma is not a good indicator of B6 deficiency. Am. J. Clin. Nutr. 55:1154-60
93. 93. Morita H, Kurihara H, Tsubaki S, Sugiyama T, Hamada C, et al. 1998. Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese. Arterioscler. Thromb. Vasc. Biol. 18:1465-69
94. 94. Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, et al. 1997. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 95:2032-36
95. 95. Motulsky A. 1996. Nuritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am. J. Hum. Genet. 58:17-20
96. 96. Mudd SH, Ebert MH, Scriver CR. 1980. Labile methyl group balances in the human: the role of sarcosine. Metabolism 29:707-20
97. 97. Mudd SH, Havlik R, Levy HL, McKusick VA, Feinleib M. 1981. A study of cardiovascular risk in heterozygotes for homocystinuria. Am. J. Hum. Genet. 33:883-93
98. 98. Mudd SH, Levy HL, Morrow G. 1970. Deranged B12 metabolism: effects on sulfur amino acid metabolism. Biochem. Med. 4:193-214
99. 99. Mudd SH, Levy HL, Skovby F. 1995. Disorders of transsulfuration. In The Metabolic and Molecular Basis of Inherited Disease, ed. CR Scriver, AL Beaudet, WS Sly, D Valle, pp. 1279-327. New York: McGraw-Hill
100. 100. Mudd SH, Poole JR. 1975. Labile methyl balances for normal humans on various dietary regimens. Metabolism 24:721-35
101. 101. Mudd SH, Uhlendorf BW, Freeman JM, Finkelstein JD, Shin VE. 1972. Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity. Biochem. Biophys. Res. Commun. 46:905-12
102. 102. Munnich A, Saudbray JM, Dautzenberg MD, Parvy P, Ogier H, et al. 1983. Diet-responsive proconvertin (factor VII) deficiency in homocystinuria. J. Pediatr. 102:730-34
103. 103. Nakata Y, Katsuya T, Takami S, Sato N, Fu Y, et al. 1998. Methylenetetrahydrofolate reductase gene polymorphism: relation to blood pressure and cerebrovascular disease. Am. J. Hypertens. 11:1019-23
104. 104. Naurath HJ, Joosten E, Riezler R, Stabler SP, Allen RH, Lindenbaum J. 1995. Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet 346:858-59
105. 105. Nishinaga M. Ozawa T. Shimada K. 1993. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. J. Clin. Invest. 92:1381-86
106. 106. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med. 337:230-36
107. 107. Okada G, Teraoka H, Tsukada K. 1981. Multiple species of mammalian S-adenosylmethionine synthase. Partial purification and characterization. Biochemistry 20:934-40
108. 108. Ou T, Yamakawa-Kobayashi K, Arinami T, Amemiya H, Fujiwara H, et al. 1998. Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study. Atherosclerosis 137:23-28
109. 109. Palareti G, Salardi S, Pizzi S, Legnani C, Poggi M, et al. 1986. Blood coagulation changes in homocystinuria: effects of pyridoxine and other specific therapy. J. Pediatr. 109:1001-6
110. 110. Pancharunity N, Lewis CA, Sauberlich HE, Perkins LL, Go RCO, et al. 1994. Plasma homocysteine, folate and B6 concentrations and the risk for early-onset coronary artery disease. Am. J. Clin. Nutr. 59:940-48
111. 111. Park YK, Linkswiler H. 1970. Effect of vitamin B6 depletion in adult man on the excretion of cystathionine and other methionine metabolites. J. Nutr. 100:110-16
112. 112. Refsum H, Ueland PM, Nygard O, Vollset SE. 1998. Homocysteine and cardiovascular disease. Annu. Rev. Med. 49:31-62
113. 113. Reinhardt D, Sigusch HH, Vogt SF, Farker K, Muller S, Hoffmann A. 1998. Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and the risk of coronary artery disease. Eur. J. Clin. Invest. 28:20-23
114. 114. Riggs KM, Spiro A, Tucker K, Rush D. 1996. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the normative aging study. Am. J. Clin. Nutr. 63:306-14
115. 115. Rolland PH, Friggi A, Barlatier A, Piquet P, Latrille V, et al. 1995. Hyperhomocysteinemia induced vascular damage in minipig. Captopril-hydrochlorotiaziade combination prevents elastic alterations. Circulation 91:1161-74
116. 116. Rosenblatt DS. 1989. Inherited disorders of folate transport and metabolism. See Ref. 37, pp. 2049-64
117. 117. Rosenquist TH, Ratashak SA, Selhub J. 1996. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc. Natl. Acad. Sci. USA 93:15227-32
118. 118. Rubba P, Faccenda F, Pauciullo P, Carbone L, Mancini M, et al. 1990. Early signs of vascular disease in homocystinuria: a non-invasive study by ultrasound methods in eight families with cystathionine-ß-synthase deficiency. Metabolism 39:1191-95
119. 119. Sardharwalla IB, Fowler B, Robins AJ, Komrower GM. 1974. Detection of heterozygotes for homocystinuria. Arch. Dis. Child. 49:553-59
120. 120. Schmitz C, Lindpaintner K, Verhoef P, Gazaino JM, Buring J. 1996. Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction: a case-control study. Circulation 94:1812-14
121. 121. Schwartz SM, Siscovick DS, Malinow MR, Rosendaal FR, Beverly RK, et al. 1997. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation 96:412-17
122. 122. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. 1993. Vitamin status and intake as primary determinants of homocysteinemia in the elderly. JAMA 270:2693-98
123. 123. Selhub J, Miller JW. 1991. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am. J. Clin. Nutr. 55:131-38
124. 124. Selhub J, Miller JW. 1994. Regulation of plasma homocysteine concentration by nutrients and drugs. In Methionine Metabolism: Molecular Mechanisms and Clinical Implications, ed. JM Mato, A Caballero, pp. 89-98. Madrid: Cons. Super. de Invest. Cient.
125. 125. Shih VE, Salam MZ, Mudd SH, Uhlendorf BW, Adams RD. 1972. A new form of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Pediatr. Res. 6:395
126. 126. Shimakawa T, Nieto FJ, Malinow MR, Chambless LE, Schreiner PJ, Szklo M. 1997. Vitamin intake: a possible determinant of plasma homocyst(e)ine among middle-aged adults. Ann. Epidemiol. 7: 285-93
127. 127. Smolin LA, Benevenga NJ. 1984. Factors affecting the accumulation of homocyst(e)ine in rats deficient in vitamin B6. J. Nutr. 114:103-11
128. 128. Stabler SP, Marcell PD, Podell ER, Allen RH, Savage DG, Lindenbaum J. 1988. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas-chromatography-mass spectrometry. J. Clin. Invest. 81:466-74
129. 129. Stamler JS, Osborne JA, Jaraki M, Rabbini LE, Mullins M, et al. 1993. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J. Clin. Invest. 91:308-18
130. 130. Steegers-Theunissen RP, Boers GH, Blom HJ, Nijhuis JG, Thomas CMG, et al. 1995. Neural tube defects and elevated homocysteine levels in amniotic fluid. Am. J. Obstet. Gynecol. 172:1436-41
131. 131. Swift M, Morrell D. 1982. Cardiovascular risk in homocystinuria family members. Am. J. Hum. Genet. 34:1016-18
132. 132. Swift ME, Schultz TD. 1986. Relationship of vitamins B6 and B12 to homocysteine levels: risk for coronary heart disease. Nutr. Rep. Int. 34:1-14
133. 133. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. 1997. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 95:1119-21
134. 134. Tsai J-C, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, et al. 1994. Promotion of vascular smooth muscle cell growth by homocysteine: a link to athersoclerosis. Proc. Natl. Acad. Sci. USA 91:6369-73
135. 135. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ. 1993. Vitamin B12, vitamin B6, and folate nutritional status in men with hyperhomocysteinemia. Am. J. Clin. Nutr. 57:47-53
136. 136. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ, Delport R, Potgieter HC. 1994. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J. Nutr. 124:1927-33
137. 137. Ueland PM, Refsum H, Male R, Lillehaug JR. 1986. Disposition of endogenous homocysteine by mouse fibroblast C3H/10T1/2 CI 8 and the chemically transformed C3H/10T1/2 MCA CI 16 cells following methotrexate exposure. J. Natl. Cancer Inst. 77:283-89
138. 138. Uhlemann ER, TenPas JH, Lucky AW, Schulman JD, Mudd SH, Shulman NR. 1976. Platelet survival and morphology in homocystinuria due to cysthationine synthase deficiency. N. Engl. J. Med. 295: 1283-86
139. 139. Upchurch GR Jr, Welch GN, Freedman JE, Loscalzo J. 1995. Homocysteine attenuates endothelial glutathione peroxidase and thereby potentiates peroxide-mediated cell injury. Circulation 92:1086
140. 140. van den Berg N, Franken DG, Boers GHJ, Blom HJ, Jakobs C, et al. 1994. Combined vitamin B-6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. J. Vasc. Surg. 20:933-40
141. 141. Verhoef P, Kok FJ, Kluijtmans LA, Blom HJ, Refsum H, et al. 1997. The 677C-T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis 13:105-13
142. 142. Verhoef P, Rimm EB, Hunter DJ, Chen J, Willett WC, et al. 1998. A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among U.S. men. J. Am. Coll. Cardiol 32:353-59
143. 143. Wagner C, Briggs WT, Cook RJ. 1985. Inhibition of glycine N-methyltransferase activity by folate derivatives: implications for regulation of methyl group metabolism. Biochem. Biophys. Res. Commun. 127:746-52
144. 144. Wang H, Yoshizumi M, Lai KH, Tsai JC, Perrella MA, et al. 1997. Inhibition of growth and p21 ras methylation in vascular endothelial cells by homocysteine but not cysteine. J. Biol. Chem. 272:25380-85
145. 145. Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, et al. 1995. Mice deficient in cystathionine ß-synthase: animal models for mild and severe homocyst(e)inemia. Proc. Natl. Acad. Sci. USA 92:1585-89
146. 146. Wilcken DEL. 1997. MTHFR 677C-T mutation, folate intake, neural-tube defect, and risk of cardiovascular disease. Lancet 350:603-4
147. 147. Wilcken DEL, Dudman NPB, Tyrrell PA, Robertson MR. 1988. Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease. Metabolism 37:697-701
148. 148. Wilcken DEL, Gupta VJ, Betts AK. 1981. Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism. Clin. Sci. 61:743-49
149. 149. Wilcken DEL, Wang XL, Sim AS, McCredie RM. 1996. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Arterioscler. Thromb. Vasc. Biol. 16:878-82
150. 150. Wilcken DEL, Wilcken B. 1976. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J. Clin. Invest. 57:1079-82